Search | Page 15 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Kathryn (Kate) Bauer, Retired MDS Patient Living Life to the Fullest Since Transplant

    ... and just having fun. Then, in August 2009, I had a blood test and it showed something was off with my white and red blood cells. I had a repeat blood test in September and it ...

    Patient Chronicle last updated 07/23/2015 - 9:38am.

  2. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.

  3. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Giving an infusion of the donor's T cells ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  4. Prognostic value of telomere attrition in patients with aplastic anemia

    ... patients are more likely to have a normalization of their blood counts versus relapse or progress to MDS. Throughout the medical ... to outcome in SAA, telomere length (TL) was measured in the white blood cells of 183 patients treated at the NIH with IST ( ...

    Research Review last updated 05/02/2016 - 9:25am.

  5. Lower-Risk MDS: Diagnosis and Treatment Options

    ... or higher-risk. The first criterion is the number of low blood counts, specifically defined as hemoglobin level less than 10 ... is the percentage of blasts , or immature white blood cells in the bone marrow , categorized as less than 5%, 5 to ...

    Interview last updated 05/18/2012 - 1:28pm.

  6. Research Overview - Recent Past Progress and Projections for the Near-Term

    ... destined to die, which is the reason for peripheral blood cytopenias. So we rely upon studying fresh patient bone marrow specimens ... a receptor called TLR-4 and also directly binds to white blood cell precursors in the bone marrow to activate their cell ...

    Interview last updated 02/10/2014 - 9:40am.

  7. Understanding Prognosis in MDS

    ... where the marrow is trying to make the correct amount of all blood cells as evidenced by the high degree of cellular activity—red blood cells, white blood cells, and platelets—but is unable to do so. What does ...

    Interview last updated 05/02/2012 - 4:36pm.

  8. PNH: Diagnosis

    ... years before they get a correct diagnosis. 3 Types of Blood Cells With PNH, your doctor can usually divide your blood cells ... from your red blood cells. It can also be done on certain white blood cells called granulocytes. FLAER is a new type of flow ...

    Page last updated 01/20/2015 - 4:48pm.

  9. Clinical Trials Report for February 2015

    ... combination will also be studied. hATG is made from horse blood and targets immune cells known as T-lymphocytes. Since T-lymphocytes are ... of MDS. Filgrastim and pegfilgrastim are designed to cause white blood cells to grow. This may help to fight infections and help improve ...

    Page last updated 01/29/2015 - 10:10am.

  10. MDS and MDS/MPN: Past, Present, and Future 2014 American Society of Hematology (ASH) Satellite Symposium Summary for Patients and Families

    ... and clinicians use conventional cytogenetics to diagnose blood disorders, predict outcomes in patients with these disorders, and develop ... features of myeloproliferative diseases, such as too many white blood cells. The disease also has features of MDS, such as formation by ...

    Page last updated 03/13/2015 - 5:00pm.